Featured Research

from universities, journals, and other organizations

New hope offered to patients with severe aortic stenosis

Date:
November 14, 2013
Source:
Baylor Health Care System
Summary:
The Heart Hospital Baylor Plano became the first in the nation to treat a patient with the catheter-based SAPIEN 3 heart valve using the transapical approach (through the ribs). This new phase of a clinical trial, also known as Partner II, may offer older patients with inoperable heart valve conditions a second chance at life.

The Heart Hospital Baylor Plano became the first in the nation to treat a patient with the catheter-based SAPIEN 3 heart valve using the transapical approach (through the ribs). This new phase of a clinical trial, also known as Partner II, may offer older patients with inoperable heart valve conditions a second chance at life.

Related Articles


Edwards Lifesciences Corp. created the transcatheter aortic valve replacement (TAVR) treatment option, which can give patients the opportunity to have their valves replaced without open-heart surgery. While a version of this product is approved by the U.S. Food and Drug Administration (FDA), it is the only one approved at this time. Additionally, there is no drug therapy for this type of valve condition.

Prior to the availability of TAVR, patients with high risk heart valve conditions , or determined to be inoperable, often went untreated. At the Heart Hospital Baylor Plano the heart team takes a comprehensive approach to evaluate these high-risk patients to determine the best treatment options. The team offers patients access to early stage TAVR clinical trials, the latest heart valve devices and a physician heart team with more than 10 years' experience in transcatheter valve therapy.

"The Heart Hospital's mission is to offer the latest, cutting-edge treatments to patients and achieve the highest quality outcomes. We're thrilled to be among 25 sites to be awarded an investigational treatment that offers patients a variety of options to replace their heart valve via a catheter-based approach. This Transcatheter Aortic Valve Replacement not only helps to extend a patient's life but, more importantly, it enhances their quality of life. We're excited that Edwards Lifesciences Corp. continues to provide new innovations that allow surgical teams across the globe to expand offerings to high-risk, inoperable patients," said David L. Brown, MD, Director of Interventional Cardiology and Transcatheter Valve Therapy.

Edwards Lifesciences Corp. received conditional approval from the FDA in August to initiate a clinical trial of the SAPIEN 3 device. The trial is evaluating the safety and effectiveness of the valve for the treatment of high-risk and inoperable patients with severe, symptomatic, aortic stenosis. The trial will enroll up to 500 patients to be treated with one of three delivery techniques: the transfemoral approach through an incision in the leg, the transapical route using a small incision on the side, and the transaortic approach through a small incision in the chest and aorta.


Story Source:

The above story is based on materials provided by Baylor Health Care System. Note: Materials may be edited for content and length.


Cite This Page:

Baylor Health Care System. "New hope offered to patients with severe aortic stenosis." ScienceDaily. ScienceDaily, 14 November 2013. <www.sciencedaily.com/releases/2013/11/131114155756.htm>.
Baylor Health Care System. (2013, November 14). New hope offered to patients with severe aortic stenosis. ScienceDaily. Retrieved October 25, 2014 from www.sciencedaily.com/releases/2013/11/131114155756.htm
Baylor Health Care System. "New hope offered to patients with severe aortic stenosis." ScienceDaily. www.sciencedaily.com/releases/2013/11/131114155756.htm (accessed October 25, 2014).

Share This



More Health & Medicine News

Saturday, October 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Texas Nurse Nina Pham Cured of Ebola

Texas Nurse Nina Pham Cured of Ebola

AFP (Oct. 25, 2014) — An American nurse who contracted Ebola while caring for a Liberian patient in Texas has been declared free of the virus and will leave the hospital. Duration: 01:01 Video provided by AFP
Powered by NewsLook.com
Toxin-Packed Stem Cells Used To Kill Cancer

Toxin-Packed Stem Cells Used To Kill Cancer

Newsy (Oct. 25, 2014) — A Harvard University Research Team created genetically engineered stem cells that are able to kill cancer cells, while leaving other cells unharmed. Video provided by Newsy
Powered by NewsLook.com
IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) — IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) — A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins